Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$42.05 - $47.77 $322,271 - $366,109
7,664 Added 10.26%
82,334 $3.58 Million
Q1 2022

May 13, 2022

BUY
$40.23 - $47.74 $381,219 - $452,384
9,476 Added 14.54%
74,670 $3.25 Million
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $505,245 - $588,803
12,995 Added 24.9%
65,194 $2.88 Million
Q3 2021

Nov 15, 2021

BUY
$38.79 - $43.16 $309,389 - $344,244
7,976 Added 18.04%
52,199 $2 Million
Q2 2021

Aug 24, 2021

BUY
$36.52 - $41.46 $9,641 - $10,945
264 Added 0.6%
44,223 $1.76 Million
Q1 2021

May 07, 2021

SELL
$34.27 - $40.01 $60,418 - $70,537
-1,763 Reduced 3.86%
43,959 $1.57 Million
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $103,368 - $121,177
-3,034 Reduced 6.22%
45,722 $1.68 Million
Q3 2020

Nov 13, 2020

SELL
$38.11 - $42.99 $138,415 - $156,139
-3,632 Reduced 6.93%
48,756 $1.84 Million
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $250,775 - $288,586
6,622 Added 14.47%
52,388 $2.14 Million
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $135,334 - $203,523
4,168 Added 10.02%
45,766 $1.73 Million
Q4 2019

Feb 13, 2020

BUY
$42.0 - $48.25 $4,284 - $4,921
102 Added 0.25%
41,598 $1.96 Million
Q3 2019

Nov 13, 2019

BUY
$40.46 - $43.52 $322,749 - $347,159
7,977 Added 23.8%
41,496 $1.77 Million
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $898,595 - $973,858
22,807 Added 212.91%
33,519 $1.34 Million
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $133,837 - $148,134
3,470 Added 47.91%
10,712 $448,000
Q4 2018

Feb 13, 2019

BUY
$37.8 - $42.69 $6,652 - $7,513
176 Added 2.49%
7,242 $277,000
Q3 2018

Nov 14, 2018

SELL
$39.75 - $42.69 $7,194 - $7,726
-181 Reduced 2.5%
7,066 $284,000
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $16,319 - $17,617
412 Added 6.03%
7,247 $292,000
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $247,290 - $274,425
6,835 New
6,835 $267,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.